AUB
REGN icon

Atlantic Union Bankshares’s Regeneron Pharmaceuticals REGN Stock Holding History

Atlantic Union Bankshares’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.58M Sell
4,634
-2,232
-33% -$1.71M 0.07% 222
2025
Q4 		$5.3M Sell
6,866
-249
-3% -$169K 0.1% 182
2025
Q3 		$4M Buy
7,115
+2,818
+66% +$1.59M 0.08% 221
2025
Q2 		$2.26M Sell
4,297
-40
-0.9% -$22.3K 0.05% 248
2025
Q1 		$2.75M Buy
4,337
+341
+9% +$235K 0.17% 125
2024
Q4 		$2.85M Buy
3,996
+1,729
+76% +$1.45M 0.17% 127
2024
Q3 		$2.38M Buy
2,267
+203
+10% +$226K 0.14% 143
2024
Q2 		$2.17M Buy
2,064
+515
+33% +$499K 0.14% 136
2024
Q1 		$1.49M Buy
1,549
+115
+8% +$109K 0.13% 149
2023
Q4 		$1.26M Buy
1,434
+328
+30% +$270K 0.12% 159
2023
Q3 		$910K Buy
1,106
+163
+17% +$128K 0.09% 172
2023
Q2 		$678K Buy
943
+677
+255% +$522K 0.07% 193
2023
Q1 		$219K Buy
+266
New +$201K 0.02% 262

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Atlantic Union Bankshares's REGN Position: Q1 2026 in Review

Atlantic Union Bankshares reduced its Regeneron Pharmaceuticals (REGN) stake by 33% in Q1 2026, selling an estimated $1.71M and leaving 4,634 shares worth $3.58M. The position accounts for 0.07% of the portfolio, ranked #222.

Atlantic Union Bankshares first reported a position in REGN in Q1 2023 and has held it in 13 quarters since. The position peaked at $5.3M in Q4 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Atlantic Union Bankshares held 4,634 shares of Regeneron Pharmaceuticals worth $3.58M as of Q1 2026.
  • Atlantic Union Bankshares sold 2,232 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $1.71M.
  • Regeneron Pharmaceuticals made up 0.07% of Atlantic Union Bankshares's portfolio in Q1 2026, its #222 holding.
  • Atlantic Union Bankshares first reported a position in Regeneron Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
  • Atlantic Union Bankshares's Regeneron Pharmaceuticals position peaked at $5.3M in Q4 2025.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.